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Abstract
We characterized the evolution of simian immunodeficiency virus (SIV) in the male genital tract by examining blood- and
semen-associated virus from experimentally and sham vaccinated rhesus monkeys during primary infection. At the time of
peak virus replication, SIV sequences were intermixed between the blood and semen supporting a scenario of high-level
virus ‘‘spillover’’ into the male genital tract. However, at the time of virus set point, compartmentalization was apparent in 4
of 7 evaluated monkeys, likely as a consequence of restricted virus gene flow between anatomic compartments after the
resolution of primary viremia. These findings suggest that SIV replication in the male genital tract evolves to
compartmentalization after peak viremia resolves.
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Introduction
An understanding of HIV-1 biology in the male genital tract will
be central to understanding the transmission of this virus. Since
HIV-1 is transmitted predominantly by sexual contact [1,2,3],
semen represents an important source of transmitted virus. While
the transmission risk of HIV-1 has been associated with virus RNA
levels in the peripheral blood of infected transmitting individuals,
virus RNA levels in the blood only serve as a surrogate for the level
of virus in ejaculate [1,3,4,5,6]. Indeed, during primary infection
when HIV-1 transmission is high, virus levels in both the blood and
the seminal plasma are both elevated [1,7]. Yet, during chronic
infection blood and semen levels of HIV-1 can be discordant [1,7].
HIV-1 exists as a diverse population of related genetic variants
that segregate into subpopulations within anatomic compartments
of infected individuals [8,9]. The intra-host compartmentalization
of these variants has been documented in multiple anatomic regions
including the peripheralblood, lungs, centralnervous system, breast
milk, gut and the female genital tract, [1,10,11,12,13,14,15,16].
Importantly, the malegenitaltract serves as a reservoir for HIV-1
that has been shown by some investigators to harbor virus that is
distinct at the sequence level from virus found in the blood
[12,15,17,18,19]. It has been suggested that this compartmentali-
zation may be a consequence of differences between the male
genitaltractandperipheraltissuesinbothimmunologicalandtarget
cell properties [14,15,20,21,22,23,24,25,26,27,28]. Histopathologic
studies of genitaltissues from SIV-infected monkeys have confirmed
that infection can occur at these sites [24,29]. Male genital tract-
derived viral variants have been reported to have unique
phenotypes with regard to drug resistance [11,30,31,32,33] and
cellular tropism [34,35]. Some groups have reported that HIV-1 in
the male genital tract [1,36,37,38] is similar to that in the blood
[39], while other groups have suggested that there is an anatomic
sequestration of virus in some individuals during primary infection
[10,34,35,40,41]. Overall, the mechanisms that contribute to
compartmentalized virus in the male genital tract are not entirely
clear. Virus compartmentalization could be the result of founder
effects, differential immune selection, altered tropism or restricted
gene flow between resident viral populations [42,43].
In the present study we sought to define the dynamics of SIV
compartmentalization in semen during primary infection in rhesus
monkeys. We accomplished this by analyzing SIV envelope (env)
sequences in the blood and semen at the peak and set point of SIV
replication in rhesus monkeys. We observed a striking progression
toward increasing viral compartmentalization over time following
infection, raising the possibility that the abrupt reduction in virus
replication that occurred in these monkeys after the resolution of
peak viremia may contribute to a restriction in viral gene flow in
and out of their genital tracts.
Results
Sequence analysis of contemporaneous blood- and
semen-derived SIV during primary infection
Twenty-six rhesus monkeys were vaccinated and then moni-
tored for 16 weeks after experimental SIV infection as previously
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nogens with a heterologous prime/boost regimen that included
both plasmid DNA and replication-defective recombinant adeno-
virus serotype 5 (Ad5) immunogens. The remaining 13 control
monkeys received sham vaccine constructs. Animals were
challenged by the i.v. route using a SIVmac251 stock with a
previously reported sequence diversity [45].
To determine whether virus in the semen and peripheral blood
were compartmentalized following infection, we assessed the
phylogenetic relationship between semen- and blood-derived SIV
env sequences. Single genome amplification (SGA) was used to
generate 789 env amplicons for sequencing and subsequent
phylogenetic analysis. Sequence data were generated from 2 time
points post-challenge, at week 2 (peak virus replication) and week
16 (virus set point).
Viral RNA levels were comparable for each group, and we
detected no significant differences in week-2 and week-16 blood or
seminal plasma viral loads between vaccinees and controls.
Similarly, no significant differences were detected between animals
included in this study and animals excluded as a result of
insufficient sequence data (Wilcoxon P.0.01) as described [44].
SIV env sequences were first generated from both the blood and
semen of 14 rhesus monkeys (7 vaccinated and 7 control) from
specimens obtained 2 weeks following infection. The genetic
diversity of the virus from each anatomic compartment of each
monkey was calculated as the average pair-wise genetic distance of
SIV env within each semen or blood population from the inoculum
consensus. Data from the vaccinated and control animals were
analyzed independently. Since these represented analyses of
sequence from virus obtained very early after infection, little
divergence was seen from the founder viruses that initiated
infection in each monkey (Table 1). Moreover, we observed little
genetic diversity between sequences of blood and semen amplicons
at this early time point after challenge, representative examples
from 4 monkeys (2 control, 2 vaccinated) are shown (Fig. 1).
Among the sequences from the blood, we observed no difference
in average pairwise env distance from the inoculum consensus per
animal between vaccinees (0.29% versus 0.28% respectively,
P=0.9). The sequence divergence for all week 2 semen isolates
were not significantly different in control and vaccinated monkeys,
with a mean distance among control animals of 0.27% and 0.15%
among vaccinated monkeys (P=0.4). These differences are
consistent with the lower levels of viral replication in the
vaccinated group [44].
We next analyzed blood and semen sequences from specimens
obtained at week 16 following infection. Post set point, we were
able to obtain sufficient numbers of concurrent semen- and blood-
derived SIV sequences from 7 monkeys to allow a phylogenetic
analysis of these viruses. Consistent with the lower level of virus
replication in the vaccinated group, we observed reduced
diversification of sequences obtained from the vaccinated mon-
keys, particularly in the seminal plasma. Specifically, blood-
derived env sequences from control animals showed a trend
towards greater divergence (0.45%) than env sequences derived
from the blood plasma of vaccinees (0.35%, P=0.2). In week 16
sequences obtained from seminal plasma, the mean pair wise
distance per animal was 0.31% and 0.22% for controls and
vaccinees, respectively (P=0.2). We next analyzed these sequence
data using available algorithms to determine if changes in N-linked
Env glycosylation sites had occurred during the sampling period
[46]. No significant changes in potential Env glycosylation sites
were observed.
We then analyzed the sequences from the inoculum and week
16 samples for evidence of selection on SIV env by fixed-effects
likelihood (FEL) [47]. As the results of this test can be influenced
by the presence of recombinant sequences, we first used G.A.R.D.
[48] to test for recombination and, if significant breakpoints
(p,0.01) resulted, performed FEL tests separately for sequence
alignments partitioned at the breakpoints.
The presence of negative selection could not be determined as
intra-host viral populations had not diversified sufficiently for such
events to occur at detectable levels. The positive selection tests that
reached significance (p,0.05) are indicated (Table S1). Among
the sequences from inoculum and week 16 sequences, we found 12
codons in 6 monkeys (3 vaccinees and 3 from the control group)
under positive selection. One of these codons was under positive
selection in 2 different animals (codon 427 in AX93 and AY47).
A number of investigators have postulated that specific amino
acid signatures may be associated with HIV found in the semen
[17,49,50]. To investigate this possibility, we applied a tree-
corrected contingency table method to identify compartment
specific amino acid signatures [51]. This analysis yielded no
evidence for specific signatures that might be associated with SIV
tropism in the semen up to 16 weeks following infection.
We then conducted additional signature analyses using only
compartmentalized animals, but a sample size of 4 compartmen-
talized animals would lack sufficient statistical power to identify
robust predictive signatures of compartmentalization. Therefore,
we adapted a related strategy used by Pillai et al. [49]. Pillai
reported a combination of HIV ENV residues (HXB2 270, 291,
387, and 464) associated with blood-semen compartmentalization.
All of these except the first are located 1-2 residues downstream of
putative N-linked glycosylation sites. We evaluated these sites in
the SIV env sequences generated in this study by identify-
ing homologous sites in HIV-1 and SIV from an alignment
that incorporates HIV-1, HIV-2, HXB2, and SMM239 Seqs.
(http://www.hiv.lanl.gov/content/sequence/NEWALIGN/align.
html).
Reviewing the homologous signature sites in the SIV env
sequences, we found 3 of 4 to be located 1–2 residues downstream
of glycosylation sites. However, mutations in these sites (and in the
neighboring 4 residues) were equally common in sequences
derived from blood and semen, regardless of whether we included
only sequences from compartmentalized animals. Thus, we were
unable to confirm semen signatures in these SIV data.
Unrestricted viral gene flow between the blood and
genital tract during early SIV infection
We then sought to determine if SIV compartmentalization was
demonstrable during primary infection. To detect compartmen-
Author Summary
Methods to reduce the transmission of HIV-1 are hindered
by a lack of information regarding early viral dynamics and
evolution in the male genital tract. In the present study, we
show that SIV in the blood and genital tract are
homogeneous during early infection, indicating facile virus
gene flow between these compartments. Importantly, the
coincidence of the resolution of primary viremia with the
decreased virus levels in genital secretions suggest that
the dramatic fall in virus replication during early infection
underlies the development of viral compartmentalization.
Our demonstration of early virus compartmentalization in
the male genital tract has important implications for the
understanding of early events leading to infection of the
male genital tract and the nature of the transmitted virus
during primary retrovirus infection.
Virus Compartmentalization and Transmission
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sequences, we applied both phylogenetic analyses and the Slatkin-
Maddison (SM) test from the HYPHY software package (v0.99b)
[52,53]. At the peak of SIV viremia, similar env sequences were
observed in the control and vaccinated animals. Importantly, we
observed the mixing of env taxa from blood- and seminal plasma-
derived virus, and the association of these sequences into closely
related phylograms (Fig. 1). Analysis of the week 2 blood and
seminal virus sequences indicated that all 14 monkeys are similar
on the basis of Neighbor-Joining (NJ) tree topologies. Importantly,
we observed clusters of intermixed monotypic blood and semen
sequences with minimal genetic divergence from the challenge
SIV env sequences, termed ‘‘clusters of identity’’ in all animals,
although the amount varied between individual monkeys (Fig. 1).
Representative NJ phylogenetic trees generated from SIV
sequences from control monkeys CK7J and CM8X (Figs. 1 A,
B), and from vaccinated monkeys AY47 and AX93 (Figs. 1 C, D)
are shown. In control monkey CK7J, we observed one cluster of
closely related semen and blood-borne sequences in the phyloge-
netic tree. In control monkey CM8X, two clusters of intermixed
blood/semen sequences are apparent in the tree structure. Similar
results were observed in the Gag-Pol vaccinated monkeys. For
example, in vaccinated monkey AY47 a single phylogenetic cluster
of interspersed semen and blood env sequences are apparent in the
tree. Monkey AX93, has three clusters of identical, monotypic
semen and blood sequences (Fig. 1 C and D).
While we did not observe topological evidence for virus
compartmentalization between the semen and blood during early
infection in any of the 14 monkeys analyzed, compartmentaliza-
tion effects were also assessed using the SM test. Applying this
metric, we observed no evidence of virus sequestration in week 2
blood- or semen-derived sequences in 13 of the 14 monkeys
(Table 2). Control monkey AX89 had compartmentalized semen
env sequences (s=14, P,0.0001) (Fig. 2). However, the presence of
large numbers of identical monotypic sequences might bias
statistical measures of compartmentalization [54,55]. To ensure
that the large numbers of isogenic sequences in the semen of AX89
were not confounding this statistical analysis, we conducted a
secondary analysis that collapsed all equivalently rooted mono-
typic sequences to a single representative env taxon. We then
applied the same SM test to the normalized set of env sequences
from monkey AX89. This modified analysis also indicated
significant compartmentalization between SIV env in the blood
and the male genital tract of monkey AX89 (s=14, P=0.0007).
Therefore, there was weak evidence for virus compartmentaliza-
tion in only 1 of the 14 monkeys by 2 weeks post-infection.
Origins of virus in the male genital tract during early
infection
We next explored the source of virus found in the male genital
tract at the time of peak viremia. By day 14 following infection,
significant levels of cell-free virus RNA and cell-associated provirus
are present in the semen of both control and vaccinated animals
(Fig. 3A) [44]. Examination of SIV env sequences from seminal
plasma and semen-associated cells from monkey CK7J using NJ-
tree parameters (Fig. 3B) indicated that several clusters of
monotypic cell-free virus were identical in sequence to the semen
provirus. Moreover, several clusters of cell-free and cell-associated
virus in the genital tract of this monkey were phylogenetically
indistinguishable from SIV env sequences derived cell-free and cell-
associated virus from the blood. These data argue that in early SIV
infection, during the period of peak viremia, there is significant
virus gene flow between anatomic compartments. There are also
significant levels of cell-associated and cell-free sources of virus
present early in infection that may constitute a source of
transmissible virus.
Male genital tract SIV compartmentalization is observed
at virus set point
By week 16 following infection, we could readily detect virus
compartmentalization by phylogenetic inference in 4 of the 7
monkeys that had sufficient numbers of sequences for analysis
(Fig. 4). Compartmentalization is evident in these trees as
independent clades consisting of sequences from one a single
sample source, i.e. blood or semen. Included as a Supplement, are
trees that combine sequencing data from both compartments at
both acute and chronic time points (Fig. S1–S10 in Text S1).
Typically, we observed that week 16 semen sequences tend to not
be associated with those from week 2, rather they are evident as
independent clades.
We also conducted an analysis, as described above, to ensure
that isogenic sequences were not confounding the statistical
analyses. This modified analysis did not significantly alter the
findings as determined by tree topology. We also applied the SM
test to phylogenies obtained from excluding duplicate sequences
(Table 3) and found that, after correction for multiple testing, two
Table 1. Quantity and diversity of sequences obtained per
sample.
ID
Vaccinee/
Control
Time
(Weeks
Post-
infection)
Blood
Seqs.
Semen
Seqs.
Informa-
tive Sites
MPD
(%)
SIVmac251
inoculum
NA NA 61 23 0.373
AX89 C 2 27 52 43 0.459
16 29 3 41 0.683
C161 C 2 31 4 17 0.351
C171 C 2 21 2 16 0.230
16 17 24 19 0.308
CK7J C 2 17 43 26 0.178
CM8X C 2 35 32 21 0.298
CP6E C 2 9 12 12 0.288
DA2D C 2 14 2 23 0.465
16 32 4 11 0.348
AX93 V 2 19 36 30 0.322
16 39 9 36 0.484
AY11 V 2 22 3 16 0.310
16 13 3 10 0.302
AY28 V 2 11 3 3 0.083
AY47 V 2 16 5 20 0.342
AY89 V 2 4 12 12 0.253
16 38 27 32 0.407
C179 V 2 9 35 19 0.289
16 19 25 21 0.313
D135 V 2 12 4 10 0.168
SIV env clones from control (C) and vaccinated (V) monkeys were amplified by
SGA from semen and blood plasma 2 or 16 weeks after infection with a
sequence-defined SIVmac251 stock. Shown are the number of sequence clones
in blood and semen, the number of phylogenetically informative sites, and the
Mean Pairwise Distance from the challenge stock.
doi:10.1371/journal.ppat.1001293.t001
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(denoted Pn).
Our inability to demonstrate definitive compartmentalization of
virus using these strategies led us to consider whether other
biologic events might be obscuring compartmentalization. There-
fore, we evaluated the possibility that recombination may
confound the SM analysis. To assess recombination effects we
applied the G.A.R.D. algorithm [48,56] and found significant
levels of recombination (P,0.001) within SIV env, (data not
shown). Next, we analyzed our data using a ‘‘segmented’’ SM-test
based on env recombination breakpoints (not shown) and found
specific regions of the SIV envelope from RMs C179 and AX89
were in fact significantly compartmentalized (P,0.0002, Fig. 5).
Virus migration between compartments
We next determined the relative levels of virus migration
between the blood and semen by computing the minimum
number of SM migration events for each inferred phylogenetic
tree. These migrations occur where an internal node exhibits a
change of sample source (blood or semen) among immediate
descendents of that node. When these migration points were
mapped directly onto phylogenies, we observed a concordance of
semen compartmentalization with the number of migration events
between these anatomic compartments, in individual monkeys.
For example, the frequent migration events between the blood and
male genital tract, as shown for monkeys C171, and DA2D
(Fig. 6A and B), are consistent with unimpeded gene flow
resulting in homogenous co-evolving SIV env populations.
Restricted migration, as shown for monkey AY89 and AX93
(Fig. 6C and D) is consistent with the independent evolution of
virus replicating in the blood and male genital tract. Therefore, we
have documented examples of both unimpeded and restricted
Figure 1. Intermixing of blood- and semen-derived env sequences during peak SIV replication. Neighbor-joining trees from vaccinated
monkeys (A) AX93, (B) AY47 and control monkeys (C) CK7J and (D) CM8X 2 weeks after challenge with a sequence-defined SIVmac251 challenge
stock (stock sequences denoted in black).
doi:10.1371/journal.ppat.1001293.g001
Table 2. SIV genetic compartmentalization at peak virus
replication.
ID
Vaccinee/
Control
wk 2
blood
n=
wk 2
semen
n= s N(s’#s) P
AX89 C 27 52 12 0 ,0.0001***
C161 C 31 4 3 950 0.095
C171 C 21 3 2 10000 1
DA2D C 14 3 2 10000 1
CK7J C 17 43 13 1325 0.1325
CM8X C 35 32 22 4873 0.4873
CP6E C 9 12 5 932 0.0932
D135 V 12 4 3 2464 0.2464
AX93 V 19 36 14 148 0.148
AY11 V 22 3 3 10000 1
AY28 V 11 3 2 10000 1
AY47 V 16 5 5 10000 1
AY89 V 4 12 4 10000 1
C179 V 9 35 8 4286 0.4286
SIV env clones from control (C) and vaccinated (V) monkeys were amplified by
SGA from semen and blood plasma 2 weeks after infection with a sequence-
defined SIVmac251 stock. Shown are the number of clones per compartment
(n), the number of Slatkin-Maddison migration events (s), and the number of
permuted replicates having at most s migrations (N(s’#s)) with associated P
values (P) from 10,000 replicate permutations.
doi:10.1371/journal.ppat.1001293.t002
Virus Compartmentalization and Transmission
PLoS Pathogens | www.plospathogens.org 4 February 2011 | Volume 7 | Issue 2 | e1001293Figure 2. Compartmentalization of blood- and semen-derived env sequences during peak SIV replication in monkey AX89. NJ tree
from control animal AX89, 2 weeks after challenge using a sequence-defined SIVmac251 stock (denoted in black).
doi:10.1371/journal.ppat.1001293.g002
Virus Compartmentalization and Transmission
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talization.
Mechanism of SIV compartmentalization in the male
genital tract
We have therefore shown there was no evidence of SIV
compartmentalization between the blood and semen in 13 of 14
monkeys analyzed at the peak of virus replication during primary
infection. However, SIV compartmentalization was evident in 4 of
the 7 analyzed monkeys by the time of virus set point.
To explore the mechanisms responsible for this changing
pattern of viral evolution in the male genital tract, we evaluated 2
virologic correlates associated with compartmentalization. First,
we observed that cell-associated virus levels in the male genital
tract during peak infection are diminished significantly in the
animals by week 8 following infection (Fig. 7A). Second, cell-free
virus levels in the semen are also significantly diminished between
weeks 2 and 16 following infection (Fig. 7B). In fact, these cell-free
virus data demonstrate a threshold effect whereby viral RNA is
only detectable in the seminal plasma when virus levels in the
blood plasma exceed 10
4 RNA copies/ml. The coincidence of the
resolution of primary viremia with the decrease in levels of virus in
genital secretions suggest that the dramatic fall in virus replication,
with the accompanying restriction of gene flow, during this early
period of infection underlies the development of viral compart-
mentalization.
Discussion
While HIV-1 transmission in humans occurs most frequently
through mucosal exposure, the present study was undertaken using
rhesus monkeys infected by intravenous inoculation of SIV using
artificial means to collect longitudinal semen samples. Although
infection by this virus and route therefore does not model mucosal
HIV-1 acquisition, the present findings have important ramifica-
tions for the understanding of early events leading to infection of
the male genital tract, and semen as a source of transmitted virus.
Low-risk sexual transmission of HIV-1 usually results in an
infection initiated by a very limited number of founder viruses
[45,57,58]. These viruses very rapidly appear in the blood after the
transmission event, presumably as a consequence of the larger
number of target cells in the blood than in the genital tract. In the
periphery, HIV or SIV rapidly replicates to high levels and any
subsequent virus diversification is likely a consequence of
differences in virus replication in these compartments, indepen-
dent of how infection was initiated.
During peak SIV replication we found little evidence for genetic
segregation of virus between the semen and blood of infected
rhesus monkeys. Instead, we observed an equilibration of SIV
Figure 3. Source of SIV in the semen-associated cell fraction. (A) Semen virus DNA levels in the control and Gag-Pol vaccinated monkeys 14
days after virus challenge. The comparisons of the data from the Gag-Pol vaccinated and control groups were analyzed using the Mann-Whitney non-
parametric T-test. The absolute number of SIV gag DNA copies was calculated as described previously [44], and is shown as log-transformed copies
per 1610
5 semen-associated cells. (B) Phylogeny of SIV env in monkey CK7J, 14 days after virus challenge with blood plasma virus, semen plasma and
semen cell-associated virus indicated.
doi:10.1371/journal.ppat.1001293.g003
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of intermixed virus sequences derived from the semen or blood. As
we applied SGA technology to generate all sequences [59,60], the
large numbers of identical sequences observed at peak virus
replication are not likely to be a methodologic artifact. Moreover,
since the SIV population size in the semen during peak virus
replication was high, error as a result of re-sampling seems unlikely
[61].
Based on the phylogenetic relationship among virus in the
semen at peak replication, significant amounts of virus appear to
be derived as a result of clonal expansion of infected cells. The
homeostatic proliferation of SIV infected cells trafficking from the
blood into genital tissues is a plausible means of producing the
oligoclonal ‘‘bursts’’ of virus observed in ejaculate. These findings
account for the magnitude and delay in peak semen viremia
relative to the blood that has been reported in acutely HIV-1
infected patients [7,36,44]. Moreover, the influx of large numbers
of SIV-infected cells into genital tissues make it unlikely that a
specific virus amino acid ‘‘signature’’ could be a determinant of
early viral tropism in the male genital tract [17], consistent with
our inability to identify SIV Env amino acids that were
significantly enriched in the seminal plasma. However, our
analysis did not span a sufficient period of time to determine the
presence of semen signatures during chronic infection [49,50].
Figure 4. Anatomic sequestration, and diversification of SIV during set point virus replication. By 16 weeks after SIV challenge,
compartmentalization of virus in semen and blood was apparent in 4 of 7 animals on the basis of tree topology and the SM test. NJ trees of SGA-
derived env amplicons for compartmentalized monkeys (A) C179, (B) AX93 (C) AX89, and (D) AY89 are shown. Note that monkey AX89 is a control
monkey and C179, AX93 and AY89 are vaccinated animals.
doi:10.1371/journal.ppat.1001293.g004
Table 3. SIV genetic compartmentalization at virus set point.
ID
Vaccinee/
Control
wk 16
blood n=
wk 16
semen n= s N(s’#s) P Pn
C171 C 17 24 12 2963 0.2963 0.7035
DA2D C 32 4 4 10000 1 1
AX89 C 29 3 1 9 0.0009*** 0.0250*
C179 V 19 25 10 118 0.0118* 0.0233*
AX93 V 39 9 2 0 ,0.0001*** ,0.0001***
AY11 V 14 3 2 10000 1 NA
AY89 V 38 27 1 0 ,0.0001*** ,0.0001***
SIV env clones from control (C) and vaccinated (V) monkeys were amplified by SGA from semen and blood plasma 16 weeks after infection with a sequence-defined
SIVmac251 stock. Shown are the number of clones per compartment (n), the number of Slatkin-Maddison migration events (s), and the number of permuted replicates
having at most s migrations (N(s’#s)) with associated P values from 10,000 replicate permutations, and P values from trees normalized by eliminating multiple copies
of identical sequences (Pn).
doi:10.1371/journal.ppat.1001293.t003
Virus Compartmentalization and Transmission
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during early infection results in a ‘‘wave’’ or spillover of cell-free
and cell-associated virus into the male genital tract, equilibrating
virus between the two compartments. Host control of SIV
replication results in a receding ‘‘tide’’ of virus as virologic set
point is achieved. When peak virus replication is reduced to levels
below the threshold required for intra-compartment gene flow,
free virus or infected cells may be effectively ‘‘trapped’’ within the
genital tissues at ‘‘low tide.’’ Continued replication of virus in the
male genital tract, in the absence (or reduced rate) of inter-
compartment gene flow would then account for the localized
diversification of virus variants in the genital tissues.
Figure 5. Virus recombination obscures compartmentalization of SIV env sequences. Diagrams indicating the positions of predicted
recombination breakpoints in compartmentalized monkeys AX89, AX93 and C179 and non-compartmentalized monkey, DA2D. Recombination
effects were determined by G.A.R.D. analysis as described. Breakpoint partitions are indicated as vertical lines between inverted triangles. SIV env
regions with significant compartmentalization as determined by the partitioned SM test on partitioned sequences, P,0.0002 are highlighted in red
boxes.
doi:10.1371/journal.ppat.1001293.g005
Figure 6. Restricted gene flow between the blood and semen is temporally associated with compartmentalization. SM migration
events were plotted directly onto NJ trees for the 4 monkeys characterized 16 weeks after SIV challenge. Unrestricted viral gene flow between the
blood and semen in monkeys C171 (A) and DA2D (B), and restricted gene flow in compartmentalized monkeys AY89 (C) and AX93 (D).
doi:10.1371/journal.ppat.1001293.g006
Virus Compartmentalization and Transmission
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than in the blood of these monkeys. This finding is consistent with
the lower level of SIV replication in the genital tract than in the
blood at 16 weeks following infection. Moreover, the difference in
virus diversification in these two anatomic compartments was
particularly evident in the vaccinated monkeys after challenge (i.e.,
3 of the 4 compartmentalized monkeys), consistent with the low-
level virus replication in the male genital tract after set point [44].
Vaccine-elicited immune responses and alterations in target cells
in the genital tract may have also contributed to the observed
effects.
Although the male genital tract is generally considered to be an
immune privileged compartment, inflammatory conditions present
during acute SIV infection may facilitate the infiltration of both
free virus and infected cells. Over time, differences between the
blood and the genital tract, as a result of restrictions in gene flow
would foster local replication in the genital tract leading to the
compartmentalization observed at set point. Inflammation is a
likely cause for the trafficking of cells from the peripheral
circulation into the genital compartment, and may explain the
observations of intermittent viral shedding in the semen of
chronically HIV-infected men as a result of bacterial or viral
infection of the male genital tract [34,62,63,64,65]. We did not
determine if genital tract infections were present in any of the
animals in this study.
These apparent differences in selective pressure between the
blood and male genital tract should also be considered in light of
the reduced effective SIV population size in the genital tract as
virus set point is achieved. Virus populations of reduced size and
altered genotype relative to the blood may contribute to the
described genetic bottleneck associated with HIV-1 transmission,
highlighted by several investigators [58,66,67]. This bottleneck is
manifested by the acquisition of HIV-1 variants in newly infected
individuals that are not highly represented in the peripheral blood
of the already infected, transmitting partner. The findings in the
present study, despite limitations in experimental infection route
and virus dose, suggest an alternative explanation for these
observations. Thus, the early compartmentalization of virus in the
male genital tract, vis-a `-vis restrictions in virus gene flow, may
account for the transmission of distinct viral quasispecies that are
not represented in the blood of the already-infected individual at
the time of transmission.
Materials and Methods
Ethics statement
All Indian-origin rhesus monkeys used in this study and analysis
were maintained according to the guidelines of the NIH Guide to
the Care and Use of Laboratory Animals and the approval of the
Institutional Animal Care and Use Committee of Harvard
Medical School and the National Institute of Health. All monkeys
were housed in a facility fully accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care
International (AAALAC). All procedures were conducted in strict
accordance with the Guide for Care and Use of Laboratory
Animals, and approved by the Institutional Animal Care and Use
Committee (IACUC) of Harvard University.
Animals, vaccinations and SIV infection
This study monitored 26 adult Mamu-A*01 negative male
rhesus monkeys (Macaca mullata) that were 4–6 years of age. All
animals were confirmed as Mamu-A*01 negative by both PCR
and MHC-amplicon sequencing. All animals were screened and
found to be negative for simian immunodeficiency virus (SIV) and
simian retrovirus type D (SRV-1) prior to the initiation of this
study. All experiments were conducted in accordance with
IACUC standards. Prior to, and routinely after SIV infection, all
animals were monitored by physical exam, CBC with differential,
and T cell subset analysis. The monkeys were housed under
Biosafety level-2+ conditions.
Rhesus monkeys were immunized using a heterologous prime/
boost regimen that included both plasmid DNA and replication-
Figure 7. Association and threshold-effect between SIV DNA, and RNA levels in blood and semen. Cell-associated SIV trafficking into the
male genital tract during peak and set point SIV infection. The comparisons of the data from the Gag-Pol vaccinated and control groups were
analyzed using the Mann-Whitney non-parametric U-test. The absolute number of SIV gag DNA copies was calculated as described previously, and is
shown as log-transformed copies per 1610
5 semen-associated cells. (A). Association and threshold effect between levels in blood plasma and
seminal plasma from both vaccinated and control monkeys (B). Adapted from Whitney et al. [44].
doi:10.1371/journal.ppat.1001293.g007
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group of 13 monkeys received these vaccine vectors expressing
SIVmac239 gag, and pol, and a second group of 13 monkeys
received sham vaccine constructs. The monkeys were challenged
by the intravenous route with a pathogenic SIVmac251
quasispecies, 16 weeks after the last immunization. The exper-
imental challenge consisted of injection with a 1 ml bolus of
SIVmac251 (2.11610
5 viral RNA copies), directly into the
saphenous vein.
Sample collection and processing
Viral levels were monitored in the semen and blood for 16
weeks after infection. Specimens were collected weekly for the first
6 weeks; then bi-weekly for the study duration. Semen was
collected by eletroejaculation via rectal probe electrostimulation
as, described [68]. Briefly, stimulation is provided by rhythmic
pulsation from the stimulator, initially to 5 volts, with the voltage
increasing over a 2 second period, with the stimulus maintained
for 5–15 seconds and being reduced over 2 seconds. This rhythm
is repeated with the maximum voltage increasing in 3-volt steps to
a maximum of 20 volts. Stimulation can be repeated. Seminal
emission is collected into a sterile container. Semen was
centrifuged immediately after collection at 4uC and immediately
frozen at 280uC. Semen cell pellets were washed 36in cold PBS
followed by the addition of 250 mlo fRNAlater (Ambion, Austin,
TX). Samples were immediately frozen and maintained at 280uC
until use.
SIV RNA isolation qRT-PCR and assay evaluation
Viral RNA levels were monitored in the seminal plasma and
semen-associated cell fraction for 16 weeks after infection. Viral
RNA was routinely isolated from 200 mL of cell-free, clarified
peripheral blood or seminal plasma using the NucliSENS Isolation
Kit (Biomerieux, Lyon, France) following the manufacturer’s
protocol.
The SIV RNA standard was transcribed from the pSP72 vector
containing the first 731 bp of the SIVmac239-Gag gene using the
Megascript T7 kit (Ambion Inc.). RNA was isolated by phenol-
chloroform purification followed by ethanol precipitation. All
purified RNA preparations were quantified by optical density.
RNA quality was determined by Agilent bioanalyzer RNA chip
(Agilent Inc., Santa Clara CA).
QRT-PCR was conducted in a 2-step process. First, RNA was
reverse transcribed in parallel with an SIV-gag RNA standard
using the gene-specific primer sGag-R 59CACTAGGTGTCTC-
TGCACTATCTGTTTTG-39under the following conditions: the
50 mL reactions containing 16buffer (250 mM Tris-HCL pH 8.3,
375 mM KCl, 15 mM MgCl2), 0.25 mM primer, 0.5 mM dNTPs
(Roche), 5 mM dTT, 500 U Superscript III RT (Invitrogen,
Carlsbad, CA), 100 U RnaseOUT (Invitrogen), and 10 mLo f
sample. RT conditions were 1 hour at 50uC, 1 hour at 55uC and
15 minutes at 70uC. All samples were then treated with RNAse H
(Stratagene) for 20 minutes at 37uC. All real-time PCR reactions
used EZ RT PCR Core Reagents (Applied Biosystems, Foster
City, CA) following the manufacturer’s suggested instructions
under the following conditions: the 50mL reactions containing 16
buffer (250 mM Bicine, 575 mM potassium acetate, 0.05 mM
EDTA, 300 nM Passive Reference 1, 40% (w/v) glycerol, pH 8.2,
.3 mM each of dATP, dCTP, dGTP, .6 mM dUTP, 3 mM Mn
(OAc)2, .5 U uracil N-glycosylase, 5 U rTth DNA Polymerase,
.4 uM of each primer, and 10mL of sample template. Following
2 minutes at 50uC, the polymerase was activated for 10 minutes at
95uC, and then cycling proceeded at 15 seconds at 95uC and
1 minute at 60uC for fifty cycles. Primer sequences were adapted
from those described by Cline et al [69], forward primer s-Gag-F:
59-GTCTGCGTCATCTGGTGCATTC-39, reverse primer s-
Gag-R: 59-CACTAGGTGTCTCTGCACTATCTGTTTTG-39,
and the probe s-Gag-P: 59-CTTCCTCAGTGTGTTTCACTTT-
CTCTTCTGCG-39, linked to Fam and BHQ (Invitrogen,
Carlsbad, CA). All reactions were carried out on a 7300 ABI
Real-Time PCR system (Applied Biosystems) in triplicate accord-
ing to the manufacturer’s protocols.
Preliminary experiments were done to evaluate the quantitation
of blood, and seminal plasma viral RNA levels and their
correlation with known viral RNA quantities spiked into blood
or semen sampled from SIV-uninfected monkeys (data not shown).
To determine the linear range of the assay, RNA extraction
efficiency and potential inhibition of reverse transcriptase activity,
known quantities of serially diluted SIVmac251 viral stock were
spiked into samples of peripheral blood, or semen that were
recovered from three SIV-naı ¨ve monkeys. No significant differ-
ences in extraction efficiency were observed between the blood
and samples derived from other compartments (data not shown).
Furthermore, using the extraction methods described above, we
observed no inhibition of RT activity or diminution of input RNA
as a consequence of RNAse activity present in any of the virus-
spiked specimens (data not shown). These findings indicated,
therefore, that it was appropriate to employ this technique to
isolate viral RNA from study samples of peripheral blood and
semen from infected rhesus monkeys. The analytical sensitivity of
our quantitative RT-PCR assay was determined as described
[44,70].
Detection of viral DNA
Cellular DNA was isolated using a QIAamp DNA Mini kit
(QIAGEN). The number of SIV gag DNA copies was calculated as
described previously [71,72] and is shown as log-transformed
copies per 1610
5 semen-associated cells. All target sequences were
normalized to Albumen levels in genomic DNA in multiplex
reaction performed in duplicate (Vic-labelled Taqman reagents,
Applied Biosystems).
Single genome sequencing of SIV envelope
Viral cDNA was diluted in 96-well plates to yield fewer than 30%
wells positive for amplification to ensure that positive amplifications
were a result of a single cDNA (Palmer et al., 2005). First-round
PCR was carried out in a reaction mixture containing: 16buffer
(Platinum Taq HF Kit, Invitrogen), 0.2 mM dNTP mix, 2mM
Mg2SO4, 0.2 mM primer OF6207 (59 – GGGTAGTGGAGGTT-
CTGGAAG – 39), 0.2 mM primer OR9608 (59 – CTCATCTGA-
TACATTTACGGGG – 39), 0.025 units of Platinum Taq High
Fidelity polymerase in a total volume of 20 mL. PCR mixtures were
loaded into MicroAmp Optical 96-Well Reaction Plates (Applied
Biosciences). PCR conditions were programmed as follows:
5 minutes at 94uC, 35 cycles of 15 seconds at 94uC, 30 seconds at
52uC, 4 minutes and 15 seconds at 68uC, followed by a final
extension time of 10 minutes at 68uC [59]. For the second-round
PCR, 2 mL of first-round PCR product was mixed with 16buffer
(Platinum Taq HF Kit, Invitrogen), 0.2 mM dNTP mix, 2mM
Mg2SO4, 0.3 mM primer IF6428 (59 – CGTGCTATAACA-
CATGCTATTG – 39), 0.3 mM primer IR9351 (59 – CCCTAC-
CAAGTCATCATCTTC – 39), 0.025 units of Platinum Taq High
Fidelity polymerase in a total volume of 20 mL. PCR conditions
were: 5 minutes at 94uC, 45 cycles of 15 seconds at 94uC,
30 seconds at 51uC, 3 minutes and 30 seconds at 68uC, followed
by a final extension time of 10 minutes at 68uC. Amplicons from
cDNA dilutions resulting in less than 30% positive wells were
Virus Compartmentalization and Transmission
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Resource Core.
Raw cDNA sequence data was assembled using GeneCodes
Sequencher 4.8 DNA sequencing software. All assembled
sequence contigs were manually corrected for individual ambig-
uous nucleotide errors and further quality controlled to exclude
any amplicons derived from multiple templates according to that
described by Learn et al, [73]. Nucleotide alignments were made
using the GeneCutter algorithm as described below (http://www.
hiv.lanl.gov/content/sequence/GENE_CUTTER/cutter.html).
Analysis of SIV envelope diversity
The median and range of diversity was determined for each
monkey, for both blood and semen, using a strategy suggested by
Gilbert et al., that controls for the correlation of inter-sequence
distances from the same animal and compared env divergence
between animals receiving vaccine or sham-vaccinated controls.
We modified the method described by Gilbert et al., to include a
correction for small sample size bias (Giorgi and Bhattacharya,
unpublished data), and restricted our analysis to animals those that
had more than 3 sequences [74]. A nucleotide alignment of all
sequences was generated with using GeneCutter, and then
manually refined to maintain intact codons. The aligned
sequences were trimmed to 2499 nucleotides, a region spanning
the start codon of env through the first 17 nt of nef, to yield
consistent phylogenetic signal among sequences, rather than
variable signal due to 39 gaps in some sequences but not others.
We used both Neighbor-Joining (NJ) and maximum likelihood
(ML) for phylogenetic inference. The trees in figures 1,3,4,5, and 6
are from NJ via APE, version 2.5–3 [75] and BIONJ [76] with
uncorrected pairwise distances and nodes with over 70% support
from 1000 bootstrap replicates are labeled. The trees in the
Supplementary data section were also obtained using Neighbor-
Joining, APE and BIONJ with uncorrected pairwise distances and
nodes with over 70% support from 100 bootstrap replicates are
labeled. Use of an uncorrected substitution model is justified for
representing within-host evolution because multiple mutations at
the same site are unlikely to have occurred within 25% of the
genome by 16 weeks post-infection. We inferred trees for the SM
compartmentalization tests by PhyML [77] using the HKY85
substitution model, a discrete 4-parameter approximation to a
gamma distribution of rate variation, and a term for invariant sites.
Model parameters were also obtained via ML. We independently
recomputed all trees in PAUP*, version 4.0b10 using ML
substitution model parameters and NJ trees. Aside from minor
differencesinbranchlengths and a tendency forNJto yield negative
lengths on some short branches, we did not find that results differed
whether likelihood or distance-based tree optimality criteria were
employed, regardless of the software implementation.
Analysis of compartment-specific amino acid signatures
Signature detection utilized a phylogenetic correction to avoid
over-counting amino acid substitutions among lineages of related
sequences. To do this, we used methods described previously [78],
and constructed a two-by-two contingency table for each amino-
acid site in the alignment, populating the table with counts based
on the immediate ancestor for each leaf in the tree. Columns in the
contingency table correspond to whether or not the amino acid
matches the ancestral state and rows correspond to whether the
sequence is from blood or semen. Fisher’s exact test identified
significant deviations from equal proportions of amino-acid
substitutions in blood versus semen-derived env sequences, with a
false-discovery rate correction applied to the resulting p-values to
accommodate multiple tests.
Compartmentalization tests
To test for compartmentalization in contemporaneous blood-
and semen-derived SIV env sequences, we used the Slatkin-
Maddison test [52] as implemented in the HYPHY software
package (v0.99b) as described by Pond et al. [53]. The SM test
computes s, the observed number of migration events required to
yield the observed distribution of blood and semen sequences on a
tree. It then assesses significance by comparing s with a re-sampled
null distribution, which is obtained by holding the tree topology
constant and randomly permuting the order of blood and semen
labels across all leaves on the tree, computing s for each
permutation. Statistical support for compartmentalization is
attained when a large proportion of permutations yield more
migration events than for the empirical s. That is, if fewer than 5%
of 10,000 replicate permutations have at most s migration events,
then P,0.05.
Viral recombination
Analysis for recombination was performed by the visual
inspection of Highlighter plots and confirmed by using the
G.A.R.D. analysis, where significance was assessed at (P,0.001)
(13, 14).
Methods for detecting positive selection
Protein-coding regions for all Env were tested for specific
codons under positive selection using FEL. A Neighbor-Joining
tree and nucleotide substitution model were computed for each
aligned gene before FEL analysis [47]. Sites with greater
nonsynonymous than synonymous substitution rates (dN.dS)
and P,0.05 were taken as significant for positive selection. FEL
results were not corrected for multiple testing, as according to
Pond and Frost.
Statistical inference and hypothesis testing
Statistical analysis was conducted using commercially available
software GraphPad Prism version 4.0b (GraphPad Software, Inc.
San Diego, CA 92130 USA). Linear regressions were conducted to
determine the significance of correlations. Significance of differ-
ences between groups was determined using Kruskall–Wallis
ANOVA as appropriate. Probability values of P,0.05 were
interpreted as significant.
Supporting Information
Table S1 Analysis of positively selected SIV env codons by
fixed-effects likelihood test.
Found at: doi:10.1371/journal.ppat.1001293.s001 (0.03 MB
DOC)
Text S1 Viral sequence diversity in the semen and blood after
i.v. SIVmac251 infection. NJ and Highlighter analyses of sequences
from control monkeys AX89, C171, DA2D, CK7J, CM8X (Fig.
S1–S5), and vaccinated monkeys D135, AX93, AY47, AY89 and
C179 (Fig. S6–S10). Shown on each tree are 2 weeks after
infection (blood, purple circles semen, aqua circles) or post set
point at 16 weeks after SIV challenge (blood, red circles or semen,
blue circles) compared with inoculum sequences (black symbols).
Brown points indicate sequences with three or more APOBEC-
mediated G-to-A mutations compared with consensus sequences.
Nucleotide polymorphisms in Highlighter plots are indicated as
follows: A green, C cyan, G orange, T red, Other IUPAC code
dark blue, Gap/no data grey.
Found at: doi:10.1371/journal.ppat.1001293.s002 (1.72 MB
PDF)
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